Document
type: Class

Continuant
type: Class

Entity
type: Class

Generically Dependent Continuant
type: Class

Archives of Medical Research
type: Collection
type: Thing
type: Information Content Entity
type: Entity
publication venue for: Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses
type: Periodical
type: Continuant
type: Generically Dependent Continuant
type: Journal
type: Document

Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses
most specific type: Document
type: Document
issue: 5
related by: authorship_37834
type: Continuant
page end: 294
freetext keyword: ADMA; Atherogenic index of plasma; Cardiovascular diseases; FABP4; Framingham risk score; Predictive CVD biomarkers biological marker; cholesterol; fatty acid binding protein 4; glucose; high density lipoprotein cholesterol; low density lipoprotein cholesterol; n(g),n(g) dimethylarginine; triacylglycerol; adult; aged; analytical parameters; anthropometry; Article; atherogenic index of plasma; blood sampling; cardiovascular disease; cardiovascular risk; Castelli risk index; cholesterol blood level; cross-sectional study; developing country; early diagnosis; female; Framingham risk score; glucose blood level; high density lipoprotein cholesterol level; human; low density lipoprotein cholesterol level; Mexican; normal human; predictive value; triacylglycerol blood level; adolescent; atherosclerosis; blood; cardiovascular disease; male; middle aged; risk factor; very elderly; young adult; Adolescent; Adult; Aged; Aged, 80 and over; Atherosclerosis; Cardiovascular Diseases; Cross-Sectional Studies; Female; Humans; Male; Middle Aged; Risk Factors; Young Adult
type: Generically Dependent Continuant
type: Information Content Entity
most specific type: Article
related by: authorship_37831
abstract: Background/Aim: Cardiovascular diseases (CVD) are the most important cause of mortality globally. Nevertheless, the World Health Organization have declared that a precise and quick recognition of susceptible individuals to develop CVD is imperative to combat those illnesses. Additionally, developing countries need affordable alternatives to effectively prognosticate cardiovascular events. Therefore, the objective of this study was to assess well-established clinical prognostic markers in Mexican women to identify affordable, specific, and useful tools to predict cardiovascular events. Material and Methods: A cross-sectional study was performed including 340 healthy women. Anthropometric and clinical measurements were acquired from all enrolled individuals. Also, a blood sample of each participant women was obtained to complete biochemical analyses (triglycerides, glucose, total cholesterol, LDL cholesterol, and HDL cholesterol), and serum asymmetric dimethylarginine (ADMA), and adipocyte-fatty acid binding protein (FABP4) determinations. Finally, with anthropometric, clinical and biochemical determinations, atherogenic indices (Framingham risk score, Castelli's risk index, and atherogenic index of plasma) were estimated. Results: A mean value of 6.5 ± 7.2 was detected for the Framingham risk score, 3.7 ± 1.3 for Castelli's risk index, and 0.12 ± 0.22 for the atherogenic index of plasma (AIP). Circulating mean ADMA and FABP4 levels found in assessed women were 0.68 ± 0.34 mmol/L and 20.3 ± 16.6 ng/mL, respectively. Furthermore, strong positive relationships (p <0.05) between AIP and serum FABP4 and ADMA concentrations were detected after adjustment by traditional CVD risk factors. Conclusion: In conclusion, AIP could be recommended as a potential biomarker in the early diagnosis of CVD events in developing countries. © 2019 IMSS
chemicalscas: cholesterol, 57-88-5; glucose, 50-99-7, 84778-64-3; n(g),n(g) dimethylarginine, 30315-93-6
type: Thing
crisid: 5936
type: Entity
estado: published
abstract: Background/Aim: Cardiovascular diseases (CVD) are the most important cause of mortality globally. Nevertheless, the World Health Organization have declared that a precise and quick recognition of susceptible individuals to develop CVD is imperative to combat those illnesses. Additionally, developing countries need affordable alternatives to effectively prognosticate cardiovascular events. Therefore, the objective of this study was to assess well-established clinical prognostic markers in Mexican women to identify affordable, specific, and useful tools to predict cardiovascular events. Material and Methods: A cross-sectional study was performed including 340 healthy women. Anthropometric and clinical measurements were acquired from all enrolled individuals. Also, a blood sample of each participant women was obtained to complete biochemical analyses (triglycerides, glucose, total cholesterol, LDL cholesterol, and HDL cholesterol), and serum asymmetric dimethylarginine (ADMA), and adipocyte-fatty acid binding protein (FABP4) determinations. Finally, with anthropometric, clinical and biochemical determinations, atherogenic indices (Framingham risk score, Castelli%27s risk index, and atherogenic index of plasma) were estimated. Results: A mean value of 6.5 ± 7.2 was detected for the Framingham risk score, 3.7 ± 1.3 for Castelli%27s risk index, and 0.12 ± 0.22 for the atherogenic index of plasma (AIP). Circulating mean ADMA and FABP4 levels found in assessed women were 0.68 ± 0.34 mmol/L and 20.3 ± 16.6 ng/mL, respectively. Furthermore, strong positive relationships (p <0.05) between AIP and serum FABP4 and ADMA concentrations were detected after adjustment by traditional CVD risk factors. Conclusion: In conclusion, AIP could be recommended as a potential biomarker in the early diagnosis of CVD events in developing countries. © 2019 IMSS
related by: authorship_37833
doi: 10.1016/j.arcmed.2019.08.009
origen: scopus
has funding vehicle: Consejo Nacional de Ciencia y Tecnología, CONACYT
pmid: 31593853
page start: 285
type: Article
volume: 50
has publication venue: Archives of Medical Research
date time value: article date 5936
related by: authorship_37832
e iscopus: 2-s2.0-85072839953

RDF description of Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses - http://orbis.uaslp.mx/vivo/individual/scopus5935
rights: termsOfUse
date: 2026-08-24T18:21:19
publisher: vivo
type: Document

Article
type: Class

Consejo Nacional de Ciencia y Tecnología, CONACYT
type: Relationship
type: BFO_0000020
type: Entity
type: Thing
type: Grant
type: Continuant
funding vehicle for: Atherogenic Index of Plasma: Novel Predictive Biomarker for Cardiovascular Illnesses

Information Content Entity
type: Class